Rapid response of cutaneous lupus erythematosus to treatment with the type 1 interferon receptor antagonist anifrolumab

被引：1
|
作者：
Guenther, Claudia [1 ]
机构：
[1] Tech Univ Dresden, Dept Dermatol, Univ Med Ctr Hosp, Dresden, Germany
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 02期
关键词：
SIGNATURE;
D O I：
10.1093/bjd/ljad111
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
下载
收藏
页码：151 / +
页数：2
相关论文
共 50 条
  • [1] Rapid response to anifrolumab in refractory cutaneous lupus erythematosus
    Moreno-Torres, Victor
    Martinez, Rita Cabeza
    Mellor-Pita, Susana
    MEDICINA CLINICA, 2024, 162 (11): : 555 - 556
  • [2] Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus
    Chasset, Francois
    Jaume, Lea
    Mathian, Alexis
    Abisror, Noemie
    Dutheil, Amelie
    Barbaud, Annick
    Kottler, Diane
    Girard, Celine
    Jousse-Joulin, Sandrine
    Tauber, Marie
    Livideanu, Cristina Bulai
    Avettand-Fenoel, Veronique
    Lhote, Raphael
    Pha, Micheline
    Amoura, Zahir
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (01) : 171 - 173
  • [3] Anifrolumab for treatment of refractory cutaneous lupus erythematosus
    Blum, Franklin R.
    Sampath, Ashwath J.
    Foulke, Galen T.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (11) : 1998 - 2001
  • [4] Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus
    Riggs, Jeffrey M.
    Hanna, Richard N.
    Rajan, Bhargavi
    Zerrouki, Kamelia
    Karnell, Jodi L.
    Sagar, Divya
    Vainshtein, Inna
    Farmer, Erika
    Rosenthal, Kimberly
    Morehouse, Chris
    de los Reyes, Melissa
    Schifferli, Kevin
    Liang, Meina
    Sanjuan, Miguel A.
    Sims, Gary P.
    Kolbeck, Roland
    LUPUS SCIENCE & MEDICINE, 2018, 5 (01):
  • [5] Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials
    Tanaka, Yoshiya
    Tummala, Raj
    MODERN RHEUMATOLOGY, 2021, 31 (01) : 1 - 12
  • [6] Anifrolumab Anti-interferon-α receptor 1(IFNAR1) monoclonal antibody Treatment of systemic lupus erythematosus
    Haddley, K.
    DRUGS OF THE FUTURE, 2018, 43 (07) : 471 - 481
  • [7] Anifrolumab in the treatment of systemic lupus erythematosus
    Aringer, Martin
    Nitschmann, Sirka
    INNERE MEDIZIN, 2022, 63 (09): : 1009 - 1012
  • [8] Treatment With Anifrolumab for Discoid Lupus Erythematosus
    Trentin, Francesca
    Tani, Chiara
    Elefante, Elena
    Stagnaro, Chiara
    Zucchi, Dina
    Mosca, Marta
    JAMA DERMATOLOGY, 2023, 159 (02) : 224 - 226
  • [9] An emerging role of interferon targeted therapy for the treatment of cutaneous systemic lupus erythematosus: a prospective real-world evaluation of anifrolumab for refractory cutaneous lupus
    Carter, Lucy
    Wigston, Zoe
    Laws, Philip
    Vital, Edward
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [10] Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE
    Bao, Aaron
    Petri, Michelle A.
    Fava, Andrea
    Kang, Jun
    LUPUS SCIENCE & MEDICINE, 2023, 10 (02):
12345